• About WordPress
    • WordPress.org
    • Documentation
    • Learn WordPress
    • Support
    • Feedback
  • Log In
  • Register
RxHarun
Login / Register Login/Signup
  • Health (A – Z)
  • Drugs (A – Z)
  • Rx Cancer (A – Z)
  • Rx Neurology (A – Z)
  • Rx Urology
  • Rx Lab Test (A – Z)
  • Rx Shop (A – Z)
  • Rx iT World
  • Rx Foundation

Morphine Indications, Contraindications, Warning

Dr. Harun Ar Rashid, MD - Arthritis, Bones, Joints Pain, Trauma, and Internal Medicine Specialist Dr. Harun Ar Rashid, MD - Arthritis, Bones, Joints Pain, Trauma, and Internal Medicine Specialist
10 Views
Drugs (A - Z)
  • Mechanism of Action of Morphine
  • Drug Indications of Morphine
  • Contra Indication of Morphine
  • Dosage of Morphine
  • Side Effects of Morphine
  • Drug Interactions
  • Pregnancy Category

Morphine Indications/Morphine is an opiate alkaloid isolated from the plant Papaver somniferum and produced synthetically. Morphine binds to and activates specific opiate receptors (delta, mu, and kappa), each of which are involved in controlling different brain functions. In the central nervous and gastrointestinal systems, this agent exhibits widespread effects including analgesia, anxiolysis, euphoria, sedation, respiratory depression, and gastrointestinal system smooth muscle contraction. (NCI04).

Morphine is one of the natural plant alkaloids found in opium and is the prototype opiate, against which other derivatives are measured in terms of analgesic effects and side effects. Morphine has not been linked to serum enzyme elevations during therapy or to clinically apparent liver injury.

Mechanism of Action of Morphine

It is important to consider that about 85% of the effect observed by morphine administration is due to the activity of morphine-6-glucuronide. Morphine and its metabolites act as agonists of the mu and the kappa opioid receptors which derive later into analgesia. The mu-opioid receptor is a key part of the effect of morphine in the ventral tegmental area which reinforces the effects of morphine. However, in studies with delta-opioid receptor knock-out mice, it was reported a reduction in the rewarding effect of morphine suggesting that the rewarding effect of morphine is related to activity towards the delta-opioid receptor in the nucleus accumbens. From the three target receptors of morphine, the mu receptor is associated with the side effects of the morphine such as modifications in the respiratory system and addiction.

Drug Indications of Morphine

  • Chronic Pain
  • Neonatal Abstinence Syndrome
  • Opioids, including morphine, can manage pain effectively when used for a short amount of time. The use of opioids for longer periods needs to be monitored as they can develop a physical dependence, addiction disorder, and drug abuse.
  • Morphine is used for the management of chronic moderate-to-severe pain. Opioids, including morphine, can manage pain effectively when used for a short amount of time. The use of opioids for longer periods needs to be monitored as they can develop a physical dependence, addiction disorder, and drug abuse.
  • Morphine sulfate is strong analgesia used to relieve severe, acute pain or moderate to severe, chronic pain (e.g, in terminally ill patients). The drug is also used parenterally as a supplement for analgesia during labor.
  • Chronic epidural or intrathecal administration of highly concentrated injections (i.e., Infumorph) via continuous, controlled microinfusion for the management of chronic intractable pain has been designated an orphan use by the US FDA.
  • Morphine is the drug of choice in relieving the pain of myocardial infarction.
  • Morphine is used in patients with acute pulmonary edema for its cardiovascular effects and to allay anxiety. Morphine should not be used in the treatment of pulmonary edema resulting from a chemical respiratory irritant.
  • Analgesic (narcotic), anesthetic, antitussive, antiperistaltic.
  • Morphine sulfate in controlled-release tablet form is an oral preparation being used for the relief of chronic severe pain, such as that related to cancer. A patient with adenocarcinoma of the prostate with bone metastases experienced dyspnea possibly related to the ingestion of these tablets. Discontinuing the drug quickly resulted in the disappearance of the dyspnea. The respiratory effects of morphine and the particular risks posed to the elderly patient are discussed.

Contra Indication of Morphine

  • Respiratory depression when appropriate equipment is not available
  • Although it has previously been thought that morphine was contraindicated in acute pancreatitis, a review of the literature shows no evidence for this
  • Systemic mastocytosis
  • Untreated decreased level of thyroid hormones
  • Decreased function of the adrenal gland
  • Alcohol intoxication
  • Drug abuse
  • Abnormally low blood pressure
  • Asthma Attack
  • Decreased lung function
  • Stomach or intestine blockage
  • Constipation
  • Severe liver disease
  • Biliary and gallbladder problem
  • Acute inflammation of the pancreas
  • Severe renal impairment
  • Seizures
  • Shock
  • Weakened Patient
  • High pressure within the skull
  • Chronic obstructive lung disease
  • History of opioid overdose
  • Paralysis of the intestines
  • General Ill Health and Malnutrition
  • Allergies to Opioids – Morphine Analogues and Tramadol

Dosage of Morphine

Strengths – 15 mg/mL; 10 mg; 15 mg; 30 mg; 2 mg/mL; 4 mg/mL; 8 mg/mL; 10 mg/mL; 20 mg/12 to 24 hr

Pain

Immediate-release (IR)

  • IR tablets: Initial dose: 15 to 30 mg orally every 4 hours as needed to manage pain
  • IR oral solution: Initial dose: 10 to 20 mg orally every 4 hours as needed to manage pain

Chronic Pain

Immediate-release (IR)

  • IR tablets: Initial dose – 15 to 30 mg orally every 4 hours
  • IR oral solutions: Initial dose  – 10 to 20 mg orally every 4 hours.

Extended-release (ER)

  • ER Tablets (OPIOID-NAIVE and OPIOID NON-TOLERANT): Initial dose: 15 mg orally every 8 or 12 hours
  • ER Capsules (OPIOID NAIVE): Begin treatment with an immediate-release morphine
  • ER Capsules (OPIOID NON-TOLERANT): Initial dose: 30 mg orally every 24 hours.

Pediatric Dose for Pain

Less than 6 months (not mechanically ventilated)

  • Initial dose: 0.025 to 0.03 mg/kg IV or 0.075 to 0.09 mg/kg orally every 4 to 6 hours as needed to manage pain
    6 months or older; weight less than 45 kg: 0.1 mg/kg IV or 0.3 mg/kg orally every 4 to 6 hours as needed to manage pain
    6 months or older; weight 45 kg or more:
  • Immediate-release tablets: Initial dose: 15 to 30 mg orally every 4 hours as needed to manage pain
  • Immediate-release oral solution: Initial dose: 10 to 20 mg orally every 4 hours as needed to manage pain

Side Effects of Morphine

More Common

  • dizziness, lightheadedness, or feeling faint
  • drowsiness
  • dry mouth
  • headache
  • Cramps
  • difficulty having a bowel movement
  • drowsiness
  • false or unusual sense of well-being
  • the relaxed and calm feeling
  • sleepiness or unusual drowsiness
  • weight loss
  • heartburn or indigestion
  • loss in sexual ability, desire, drive, or performance
  • muscle stiffness or tightness
  • night blindness

Common

  • Blurred vision
  • bulging soft spot on the head of an infant
  • burning, crawling, itching, numbness, prickling, “pins and needles”, or tingling feelings
  • change in the ability to see colors, especially blue or yellow
  • chest pain or discomfort
  • confusion
  • cough
  • decreased urination
  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
  • fainting
  • fast, pounding, or irregular heartbeat or pulse
  • headache
  • hives, itching, or skin rash
  • increased sweating
  • loss of appetite
  • nausea

Rare Common 

  • Constricted, pinpoint, or small pupils (black part of the eye)
  • decreased awareness or responsiveness
  • extreme drowsiness
  • fever
  • increased blood pressure
  • increased thirst
  • lower back or side pain
  • muscle cramps, spasms, pain, or stiffness
  • no muscle tone or movement
  • severe sleepiness
  • swelling of the face, fingers, or lower legs
  • weight gain

Drug Interactions

Morphine may interact with following drugs, supplements, & may change the efficacy of the drug

  • abiraterone acetate
  • alcohol
  • amphetamines (e.g., dextroamphetamine, lisdexamfetamine)
  • antihistamines (e.g, cetirizine, doxylamine, diphenhydramine, hydroxyzine, loratadine)
  • antihistamines (e.g., cetirizine, doxylamine, diphenhydramine, hydroxyzine, loratadine)
  • antipsychotics (e.g., chlorpromazine, clozapine, haloperidol, olanzapine, quetiapine, risperidone)
  • atorvastatin
  • “azole” antifungals (e.g., itraconazole, ketoconazole, voriconazole)
  • barbiturates (e.g., butalbital, pentobarbital, phenobarbital)
  • belladonna
  • benzodiazepines (e.g., alprazolam, diazepam, lorazepam)
  • beta-blockers (e.g., atenolol, metoprolol, propranolol)
  • buprenorphine
  • cimetidine
  • clopidogrel
  • crizotinib
  • cyclosporine (systemic)
  • dexamethasone
  • diuretics (water pills; e.g., furosemide, hydrochlorothiazide, triamterene)
  • droperidol
  • general anesthetics (medications used to put people to sleep before surgery)
  • glycopyrrolate
  • grapefruit juice
  • ipratropium
  • ketotifen
  • mirtazapine
  • monoamine oxidase inhibitors (MAOIs; e.g., moclobemide, phenelzine, rasagiline, selegiline, procarbazine, tranylcypromine) taken within the past 14 days
  • muscle relaxants (e.g., baclofen, cyclobenzaprine, methocarbamol, orphenadrine)
  • naltrexone
  • nilotinib
  • other narcotic analgesics (e.g., codeine, fentanyl, meperidine, oxymorphone)
  • prazosin
  • progesterone
  • St. John’s wort
  • seizure medications (e.g., clobazam, ethosuximide, felbamate, levetiracetam, phenobarbital, phenytoin, primidone, topiramate, valproic acid, zonisamide)
  • selective serotonin reuptake inhibitors (SSRIs; e.g., citalopram, duloxetine, fluoxetine, paroxetine, sertraline)
  • sunitinib
  • tacrolimus
  • tamoxifen
  • tapentadol
  • tolterodine
  • tramadol
  • tricyclic antidepressants (e.g., amitriptyline, clomipramine, desipramine, trimipramine)
  • warfarin
  • verapamil

Pregnancy Category

FDA Pregnancy Category – C

Pregnancy

This medication should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking this medication, contact your doctor immediately.

Breast-feeding

This medication passes into breast milk. If you are a breast-feeding mother and are taking morphine sustained release, it may affect your baby. Talk to your doctor about whether you should continue breast-feeding. Accidental ingestion of this medication by children may lead to severe and even fatal consequences. Keep this medication out of the reach of children.

References

  • DrugBank
    http://www.drugbank.ca/drugs/DB00295
    http://www.drugbank.ca/drugs/DB00295#targets
    http://www.drugbank.ca/drugs/DB00295#enzymes
    http://www.drugbank.ca/drugs/DB00295#transporters
    http://www.drugbank.ca/drugs/DB00295#carriers
    https://www.drugs.com/dosage/morphine.html
  • FDA Pharm Classes
    https://www.accessdata.fda.gov/spl/data/c633da78-a69f-4562-8362-a85183d41243/c633da78-a69f-4562-8362-a85183d41243.xml
    https://www.fda.gov/ForIndustry/DataStandards/StructuredProductLabeling/ucm162549.htm
  • Human Metabolome Database (HMDB)
    http://www.hmdb.ca/metabolites/HMDB0014440
  • LiverTox
    https://livertox.nlm.nih.gov/Morphine.htm
  • NCIt
    https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C62051
  • ChemIDplus
    https://chem.nlm.nih.gov/chemidplus/sid/0000057272
    https://chem.sis.nlm.nih.gov/chemidplus/
  • EPA DSSTox
    https://comptox.epa.gov/dashboard/DTXSID9023336
  • European Chemicals Agency (ECHA)
    https://echa.europa.eu/web/guest/legal-notice
    https://echa.europa.eu/substance-information/-/substanceinfo/100.000.291
    https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/58638
  • HSDB
    https://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+@rel+57-27-2
  • ClinicalTrials.gov
    https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use
    https://clinicaltrials.gov/
  • DailyMed
    https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=MORPHINE+SULFATE
    https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=EMBEDA
  • EPA Chemical and Products Database (CPDat)
    https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources
    https://comptox.epa.gov/dashboard/DTXSID9023336#exposure
    https://www.epa.gov/chemical-research/chemical-and-products-database-cpdat
  • EU Clinical Trials Register
    https://www.clinicaltrialsregister.eu/
  • FDA Medication Guides
    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=medguide.page
  • FDA Orange Book
    https://www.fda.gov/Drugs/InformationOnDrugs/ucm129662.htm
  • FDA/SPL Indexing Data
    https://www.fda.gov/ForIndustry/DataStandards/SubstanceRegistrationSystem-UniqueIngredientIdentifierUNII/
    https://www.webmd.com/drugs/2/drug-327-819/morphine-oral/morphine-oral/details/list-contraindications
  • MassBank of North America (MoNA)
    http://mona.fiehnlab.ucdavis.edu/spectra/browse?inchikey=BQJCRHHNABKAKU-KBQPJGBKSA-N
    https://chealth.canoe.com/drug/getdrug/ratio-morphine-sr
  • SpectraBase
    https://spectrabase.com/spectrum/3mDMHjua2Df
    https://spectrabase.com/spectrum/7ZL3MCLCK4j
    https://spectrabase.com/spectrum/4JkLn0p5BFi
    https://spectrabase.com/spectrum/2WsG4rydmAM
    https://spectrabase.com/spectrum/3txXq0df3dU
    https://spectrabase.com/spectrum/5DOaIh0UfoD
    https://spectrabase.com/spectrum/4CAImuUVhrV
  • NIPH Clinical Trials Search of Japan
    https://rctportal.niph.go.jp/en/
  • PDB
    http://www.rcsb.org/ligand/MOI
  • Protein Data Bank in Europe (PDBe)
    http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/MOI
  • Springer Nature
    https://pubchem.ncbi.nlm.nih.gov/substance/341155957
  • The Cambridge Structural Database
    https://www.ccdc.cam.ac.uk/structures/Search?Ccdcid=920204
  • Thieme Chemistry
    https://creativecommons.org/licenses/by-nc-nd/4.0/
  • WHO ATC
    https://www.whocc.no/atc/
    https://www.whocc.no/atc_ddd_index/
  • Wikipedia
    https://en.wikipedia.org/wiki/Morphine
    https://www.wikidata.org/wiki/Q27107392
  • MeSH
    https://www.ncbi.nlm.nih.gov/mesh/68009020
    http://www.nlm.nih.gov/mesh/meshhome.html
    https://www.ncbi.nlm.nih.gov/mesh/68000701
    https://www.ncbi.nlm.nih.gov/mesh/68009294
    https://pubchem.ncbi.nlm.nih.gov
  • KEGG
    http://www.genome.jp/kegg-bin/get_htext?br08003.keg
    http://www.genome.jp/kegg-bin/get_htext?br08303.keg
    http://www.genome.jp/kegg-bin/get_htext?br08310.keg
    http://www.genome.jp/kegg-bin/get_htext?br08330.keg
  • WIPO
    http://www.wipo.int/classifications/ipc/
  • UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS)
    http://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html
  • ChEMBL
    https://www.ebi.ac.uk/chembl/target/browser

Morphine Indications
SaveSavedRemoved 0
Morphine Indications, Contraindications, Warning
Previous

Morphine; Uses, Dosage, Side Effects, Interactions

Morphine Indications, Contraindications, Warning
Next

Dyspnea - Causes, Symptoms, Diagnosis, Treatment

Related Articles
Added to wishlistRemoved from wishlist 0
Vasodilator Drugs

Vasodilator Drugs

Added to wishlistRemoved from wishlist 0
Methamphetamine

Methamphetamine Hydrochloride – Uses, Dosage, Side Effects, Interaction

Added to wishlistRemoved from wishlist 0
Methamphetamine – Uses, Dosage, Side Effects, Interactions

Methamphetamine – Uses, Dosage, Side Effects, Interactions

Added to wishlistRemoved from wishlist 0
Vitamin D3 – Uses, Dosage, Side Effects, Interactions

Vitamin D3 – Uses, Dosage, Side Effects, Interactions

      RxHarun
      Logo
      Register New Account
      Already have an account? Login
      Log In
      Lost Password?
      Don't have an account? Sign Up

      RxHarun

      AI Chat Bot

      Dorian

      Hey, how can I help you today?

      Powered by Elementor

      Click to start chat